Everolimus Cumulative Dose and Dose Intensity in Pancreatic Neuroendocrine Tumors

被引：0
作者：
Berardi, R. [1 ]
Torniai, M. [1 ]
Pusceddu, S. [2 ]
Spada, F. [3 ]
Brizzi, M. P. [4 ]
Ibrahim, T. [5 ]
Antonuzzo, L. [6 ]
Ferolla, P. [7 ]
Panzuto, F. [8 ]
Silvestris, N. [9 ]
Partelli, S. [10 ]
Bongiovanni, A. [5 ]
Zichi, C. [4 ]
Riva, N. [5 ]
Rinzivillo, M. [8 ]
机构：
[1] Univ Politecn Marche, Ancona, Italy
[2] INT, Milan, Italy
[3] IEO, Milan, Italy
[4] San Luigi Hosp, Orbassano, Italy
[5] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy
[6] AOU Careggi, Florence, Italy
[7] Osped S Maria Misericordia, Perugia, Italy
[8] Sapienza Univ Rome, St Andrea Hosp, Sch Med, Rome, Italy
[9] Cancer Inst Giovanni Paolo II, Bari, Italy
[10] Univ Vita & Salute, Osped San Raffaele IRCCS, Milan, Italy
来源：
NEUROENDOCRINOLOGY | 2016年 / 103卷
关键词：
PNET; Dose intensity; Targeted therapy; Everolimus; Cumulative dose;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
L2
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [21] Application of low dose pancreas perfusion CT combined with enhancement scanning in diagnosis of pancreatic neuroendocrine tumors
    Wan, Yamin
    Hao, Hui
    Meng, Saisai
    Li, Zhizhen
    Yu, Fulong
    Chi, Meng
    Chao, Qi
    Gao, Jianbo
    PANCREATOLOGY, 2021, 21 (01) : 240 - 245
  • [22] Pneumocystis jirovecii pneumonia under everolimus in two patients with metastatic pancreatic neuroendocrine tumors
    Carbonnaux, Melodie
    Molin, Yann
    Souquet, Pierre-Jean
    Tantin, Arnaud
    Lombard-Bohas, Catherine
    Walter, Thomas
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (06) : 1308 - 1310
  • [23] The Efficacy of Everolimus and Sunitinib in Patients with Sporadic or Germline Mutated Metastatic Pancreatic Neuroendocrine Tumors
    Nunez, J. E.
    Donadio, M.
    Rocha Filho, D.
    Rego, J.
    Barros, M.
    Formiga, M. N.
    Lopez, R.
    Riechelmann, R.
    NEUROENDOCRINOLOGY, 2019, 108 : 176 - 176
  • [24] Pneumocystis jirovecii pneumonia under everolimus in two patients with metastatic pancreatic neuroendocrine tumors
    Mélodie Carbonnaux
    Yann Molin
    Pierre-Jean Souquet
    Arnaud Tantin
    Catherine Lombard-Bohas
    Thomas Walter
    Investigational New Drugs, 2014, 32 : 1308 - 1310
  • [25] Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: A matching-adjusted indirect comparison
    Signorovitch J.
    Swallow E.
    Kantor E.
    Wang X.
    Klimovsky J.
    Haas T.
    Devine B.
    Metrakos P.
    Experimental Hematology & Oncology, 2 (1)
  • [26] The efficacy of everolimus and sunitinib in patients with sporadic or germline mutated metastatic pancreatic neuroendocrine tumors
    Nunez, Jose Eduardo
    Donadio, Mauro
    Rocha Filho, Duilio
    Rego, Juliana Florinda
    Barros, Milton
    Formiga, Maria Nirvana
    Lopez, Rossana
    Riechelmann, Rachel
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (04) : 645 - 651
  • [27] Pancreatic neuroendocrine tumors: A comprehensive review
    Zhou, Chenfei
    Zhang, Jun
    Zheng, Ying
    Zhu, Zhenggang
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (05) : 1013 - 1022
  • [28] Biologics in gastrointestinal and pancreatic neuroendocrine tumors
    Liu, Iris H.
    Kunz, Pamela L.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (03) : 457 - 465
  • [29] Role of Radiomics in the Everolimus response prediction of metastatic neuroendocrine tumors
    Magi, L.
    Polici, M.
    Zerunian, M.
    Rinzivillo, M.
    Marasco, M.
    Iannicelli, E.
    Caruso, D.
    Annibale, B.
    Laghi, A.
    Panzuto, F.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 129 - 129
  • [30] Emerging use of everolimus in the treatment of neuroendocrine tumors
    Gajate, Pablo
    Martinez-Saez, Olga
    Alonso-Gordoa, Teresa
    Grande, Enrique
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 215 - 224
12345